(Q35194846)

7 August 2017

title

Cost of pneumococcal infections and cost-effectiveness analysis of pneumococcal vaccination at risk adults and elderly in Turkey (English)

1 reference

7 August 2017

Levent Akin

1

1 reference

7 August 2017

Mehmet Kaya

series ordinal

2

1 reference

7 August 2017

Serdar Altinel

series ordinal

3

1 reference

7 August 2017

Laure Durand

series ordinal

4

1 reference

7 August 2017

publication date

1 April 2011

1 reference

7 August 2017

1 reference

7 August 2017

volume

7

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

441-450

1 reference

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

Efficacy of pneumococcal vaccination in adults: a meta-analysis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

Pneumococcal vaccination of elderly adults: new paradigms for protection.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

Vaccines for preventing pneumococcal infection in adults

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

The burden of community-acquired pneumonia in seniors: results of a population-based study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

Effectiveness of pneumococcal polysaccharide vaccine in older adults

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

Rethinking recommendations for use of pneumococcal vaccines in adults

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

Pneumococcal vaccination for older adults: the first 20 years

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines

13 July 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.4.14188

Vaccination coverage rates in eleven European countries during two consecutive influenza seasons.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.4.14188

Alternative strategies for adult pneumococcal polysaccharide vaccination: a cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.4.14188

Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.4.14188

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.4.14188

Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.4.14188

Pneumococcal disease surveillance in Europe

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166481

Economic Evaluation of Standing Order Programs for Pneumococcal Vaccination of Hospitalized Elderly Patients

25 October 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.4.14188

The 23-Valent Pneumococcal Polysaccharide Vaccine. Part II. A Cost-Effectiveness Analysis for Invasive Disease in the Elderly in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.4.14188

Cost-effectiveness of combined outreach for the pneumococcal and influenza vaccines

21 January 2018

1 reference

12 December 2020

Pneumococcal vaccination and pneumonia: even a low level of clinical effectiveness is highly cost-effective

1 reference

12 December 2020

Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults

1 reference

12 December 2020

The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population

1 reference

12 December 2020

Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study

1 reference

12 December 2020

Protective Effects of the 23‐Valent Pneumococcal Polysaccharide Vaccine in the Elderly Population: The EVAN‐65 Study

1 reference

12 December 2020

Cost-effectiveness of vaccinating for invasive pneumococcal disease in the elderly in the Lazio region of Italy

1 reference

12 December 2020

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries

1 reference

12 December 2020

Is the pneumococcal polysaccharide vaccine effective in preventing pneumonia?

1 reference

12 December 2020

23-valent pneumococcal polysaccharide vaccine. WHO position paper

1 reference

12 December 2020

Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: A matched case–control study

1 reference

12 December 2020

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era

1 reference

12 December 2020

Identifiers

DOI

10.4161/HV.7.4.14188

1 reference

7 August 2017

1 reference

7 August 2017

1 reference